SCHEMBL29566814

SCHEMBL29566814

Cc1ccccc1Oc1nc(NS(=O)(=O)c2cnn(C)c2)nc(-c2ccccc2C)c1F

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 7/20 0.42
▸ HTR7 P34969 7/20 0.42
▸ BRAF P15056 1/20 0.37
▸ DRD2 P14416 2/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ SLC22A12 Q96S37 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ PCK1 P35558 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ KMT2A Q03164 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ SCN9A Q15858 4/20 0.33
▸ TSHR P16473 1/20 0.33
▸ EIF2AK3 Q9NZJ5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309825 1.00 HTR1A (0.42) HTR1AHTR7BRAFDRD2HTR6
SCHEMBL24309827 0.90 HTR1A (0.43) HTR1AHTR7BRAFDRD2HTR6
SCHEMBL29566900 0.90 HTR1A (0.43) HTR1AHTR7BRAFDRD2HTR6
SCHEMBL29567180 0.89 HTR1A (0.42) HTR1AHTR7BRAFDRD2HTR6
SCHEMBL24310178 0.89 HTR1A (0.42) HTR1AHTR7BRAFDRD2HTR6
SCHEMBL29567189 0.89 HTR1A (0.42) HTR1AHTR7DRD2HTR6SLC22A12
SCHEMBL24309396 0.89 HTR1A (0.42) HTR1AHTR7DRD2HTR6SLC22A12
SCHEMBL24309877 0.89 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL29566904 0.89 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24310673 0.88 HTR1A (0.40) HTR1AHTR7BRAFDRD2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback